Reviewing The Case For Standard BioTools Inc (LAB) Going Higher
Currently, there are 379.09M common shares owned by the public and among those 365.93M shares have been available to trade. The company’s stock has a 5-day price change of 17.14% and 1.65% over the past three months. LAB shares are trading -40.00% year to date (YTD), with the 12-month market performance down to -29.71% lower. […]
Standard BioTools Inc (LAB): A Great Stock For Handling Current Market Conditions?
Neuberger Berman Investment Advis recently announced the acquisition of new stake in Standard BioTools Inc (NASDAQ:LAB). The institutional investor has increased its shareholding in the Healthcare company by 0.86% to 4.54 million shares with purchase of 38558.0 shares. This fresh investment now brings its stake to 5.72% valued currently at $11.72 million. In addition, Morgan […]